Behavioral Intervention
Interactive Obesity Treatment for Pregnancy
This trial will establish the efficacy of an mHealth tool, GROWell, for achieving appropriate pregnancy weight gain and promoting postpartum weight loss among women who enter pregnancy overweight or obese.
Popular Filters
Trials for Obesity Patients
Anti-bacterial
Oral Antibiotics for Prosthetic Joint Infections
This trial is testing whether a 7-day course of an oral, prophylactic antibiotic can reduce the incidence of periprosthetic joint infection and wound complications following primary total hip and knee arthroplasty in a high-risk patient population.
ENaC inhibitor
Amiloride for Arterial Stiffness in Obesity
This trial will test whether the ENaC inhibitor amiloride can improve endothelial function and arterial stiffness in obese, insulin resistant subjects. The trial will involve pre and postmenopausal women and age-matched men.
Behavioral Intervention
Dissonance-Based Obesity Prevention + Response and Attention Training for Obesity
This trial is testing whether a novel obesity prevention program is more effective when done in single-sex versus mixed-sex groups, and whether adding food response and attention training increases weight gain prevention effects.
Trials for Metabolic Syndrome Patients
Anti-bacterial
Oral Antibiotics for Prosthetic Joint Infections
This trial is testing whether a 7-day course of an oral, prophylactic antibiotic can reduce the incidence of periprosthetic joint infection and wound complications following primary total hip and knee arthroplasty in a high-risk patient population.
ENaC inhibitor
Amiloride for Arterial Stiffness in Obesity
This trial will test whether the ENaC inhibitor amiloride can improve endothelial function and arterial stiffness in obese, insulin resistant subjects. The trial will involve pre and postmenopausal women and age-matched men.
Behavioral Intervention
Dissonance-Based Obesity Prevention + Response and Attention Training for Obesity
This trial is testing whether a novel obesity prevention program is more effective when done in single-sex versus mixed-sex groups, and whether adding food response and attention training increases weight gain prevention effects.
Phase 3 Trials
Behavioural Intervention
Lisdexamfetamine for Post-Bariatric Surgery Weight Control
This trial is testing whether the drug lisdexamfetamine can help people who have had weight-loss surgery but still struggle with controlling their eating and weight. The study focuses on those who did not improve with initial treatments, to see if this medication works better.
Combination Drug
Medication + Behavioral Therapy for Post-Bariatric Surgery Weight Control
This trial will test different treatments for people who have trouble controlling their eating and weight after weight-loss surgery. The treatments include behavior therapy to change eating habits and a combination of two medications to reduce cravings. The goal is to find out which approach works best for these patients.
ENaC inhibitor
Amiloride for Arterial Stiffness in Obesity
This trial will test whether the ENaC inhibitor amiloride can improve endothelial function and arterial stiffness in obese, insulin resistant subjects. The trial will involve pre and postmenopausal women and age-matched men.
Orforglipron for Type 2 Diabetes and Obesity
This trial is testing a new diabetes medication called orforglipron to see if it is safer and more effective than insulin in people with type 2 diabetes who are overweight or obese and at higher risk for heart problems. The study will last several years and involve multiple visits.
Behavioural Intervention
Retatrutide for Obesity
This trial is testing a weekly medication called retatrutide. It aims to help people who are overweight or obese and have knee osteoarthritis. The study will last over a year to see if the medication is safe and effective.
Trials With No Placebo
Anti-bacterial
Oral Antibiotics for Prosthetic Joint Infections
This trial is testing whether a 7-day course of an oral, prophylactic antibiotic can reduce the incidence of periprosthetic joint infection and wound complications following primary total hip and knee arthroplasty in a high-risk patient population.
Behavioral Intervention
Dissonance-Based Obesity Prevention + Response and Attention Training for Obesity
This trial is testing whether a novel obesity prevention program is more effective when done in single-sex versus mixed-sex groups, and whether adding food response and attention training increases weight gain prevention effects.
Trials Offering Remuneration
Bioactive Peptide
Egg White Powder for High Blood Sugar and High Blood Pressure
"This trial is investigating the potential benefits of a bioactive peptide called IRW, derived from egg white hydrolysate, for managing high blood sugar and blood pressure. Participants at risk for or with type
RNAi Therapeutics
ALN-KHK for Type 2 Diabetes
This trial is testing a new drug called ALN-KHK to see how safe it is and how the body processes it. They are also testing another drug called KHK to check its safety and effectiveness. The study targets patients who might benefit from these drugs, aiming to understand their safety and how they work in the body.
View More Related Trials
Frequently Asked Questions
Introduction to overweight
What are the top hospitals conducting overweight research?
In the battle against overweight and its associated health complications, several hospitals are leading the charge in innovative clinical trials. One notable institution is StudyMetrix Research in Saint Peters, which currently has eight active trials focused on tackling this prevalent issue. With a total of ten completed studies dedicated to understanding and addressing overweight, StudyMetrix Research has been at the forefront of research since their first recorded trial in 2019. Iowa Diabetes and Endocrinology Research Center in West Des Moines is also making significant strides with six ongoing overweight trials and seven previous ones conducted to explore potential solutions for combating weight-related concerns.
Additionally contributing to this cause is Arcturus Healthcare's Troy Internal Medicine Research Division located in Troy. They have initiated six ongoing clinical trials focusing specifically on overweight patients while having undertaken an impressive tally of eight previous investigations since recording their initial trial dedicated towards fighting obesity just recently backin2021.The East-West Medical Research Institute stands as another prominent facility playing a crucial role from Honolulu by conducting six active overweight clinical trials while also building upon nine previously held experiments since they began their pioneering investigation on this matter way back during2007.
Furthermore joining these efforts is North Georgia Clinical Research center based out of Woodstock where they conduct five present-day clinical tests related towards combating such cases along with five prior investigations initiated solely concerned about managing excess weight; theirs can be dated much closer within years counting only upto 2022.So whether you're seeking assistance or looking to contribute toward understanding causes or finding effective treatments for being obese each hospital mentioned actively contributes towards progress which would ultimately lead us into healthier lifestyle choices through breaking new grounds
Which are the best cities for overweight clinical trials?
When it comes to overweight clinical trials, several cities offer promising opportunities for research and development. San Antonio, Texas leads the pack with 14 active trials exploring interventions like AMG 133, Orforglipron Dose 1, and Tirzepatide. Dallas, Texas closely follows with its own set of studies focused on innovative treatments such as Tirzepatide and Retatrutide Dose 1. Meanwhile, Las Vegas in Nevada and Houston in Texas both have ongoing trials examining interventions like Tirzepatide and Orforglipron Dose 1. Lastly, New york City contributes to this field with nine active trials investigating treatments including Tirzepatide and ROADmAP schema. These cities provide individuals struggling with obesity access to cutting-edge clinical trials that contribute to advancements in weight management strategies.
Which are the top treatments for overweight being explored in clinical trials?
When it comes to exploring treatments for overweight individuals, clinical trials have identified some promising options. Leading the way is tirzepatide, a medication currently being tested in four active trials specifically targeting weight management. Since its introduction in 2019, tirzepatide has already been involved in 13 clinical trials focused on addressing overweight concerns. Another avenue being explored is lifestyle intervention, which involves making sustainable changes to one's daily habits and routines. This approach has garnered attention with two ongoing trials and a total of six past studies dedicated to understanding its impact on managing excess weight since it was first listed as a potential treatment option back in 2001. As researchers delve deeper into these avenues of investigation, they bring us closer to finding effective solutions for overweight individuals seeking healthier lives.
What are the most recent clinical trials for overweight?
Recent clinical trials have shed light on potential interventions for individuals struggling with overweight. A Phase 1 trial explored the use of LY3437943 in combination with a Combined Oral Contraceptive (COC) to address this issue. Additionally, a Phase 2 trial investigated the effectiveness of Omega-3 supplementation for managing weight-related concerns. The efficacy and safety profile of Retatrutide Dose 1 were evaluated through two separate Phase 3 trials conducted at different time points. These studies offer promising insights into potential strategies to combat overweight and improve overall health outcomes.
What overweight clinical trials were recently completed?
Several recent clinical trials have advanced the understanding and treatment of overweight individuals. In September 2021, Novo Nordisk A/S completed a trial examining the potential benefits of Oral semaglutide. Additionally, Eli Lilly and Company concluded two significant studies: one investigating LY3437943 in May 2021, and another exploring Tirzepatide in March 2021. These trials contribute to ongoing efforts to combat overweight conditions and provide hope for individuals seeking effective interventions.